The North America surgical sutures market size was estimated at USD 1.77 billion in 2025 and is projected to be worth around USD 2.83 billion by 2035, is expanding at a CAGR of 4.80% from 2026 to 2035. The market is mainly influenced by a large number of surgical procedures, an older population, and the increasing occurrence of chronic illnesses that require surgery.

North America Surgical Sutures Market Statical Scope

The North American surgical sutures market is important because it is the largest in the world, driven by high surgical activity, an aging demographic, and a well-developed healthcare system. It serves as a center for technological advancements in antimicrobial and biodegradable materials, establishing benchmarks for safety and effectiveness in surgical practices. This region leads in suture technology innovation, emphasizing antimicrobial-coated sutures to reduce infection risk, specialized bioabsorbable sutures, and products that promote faster wound healing.

With advanced healthcare facilities and robust reimbursement policies for surgical procedures, this area is the top consumer of sophisticated, high-cost sutures. The presence of key manufacturers such as Ethicon US LLC accelerates the adoption of new, advanced surgical tools and helps maintain high standards in medical production.

North America Surgical Sutures Market, By Type, 2025 (%)

• Absorbable - The absorbable segment plays a vital role in the market, driven by the growing use of minimally invasive surgeries, such as robotic and laparoscopic techniques. These sutures are favored for their ability to reduce patient trauma, eliminate the need for removal, and lower infection risks. They are designed to dissolve naturally in the body after the wound heals, capturing a 64% market share.
• Non-absorbable - The non-absorbable surgical sutures segment is important in North America, known for its high tensile strength and durability, which are crucial for long-term tissue support in cardiovascular, orthopedic, and general surgeries. These sutures, made from materials that either remain in the body or must be removed, account for 36% of the market.

North America Surgical Sutures Market, By Filament, 2025 (%)

• Monofilament - The monofilament segment is significant in the market, with growth driven by the need to reduce infection risk, improve patient comfort, and accommodate the rising number of specialized, minimally invasive, and robotic-assisted surgeries. Single-strand sutures, which allow for smooth tissue passage, dominate this segment with a 58% market share.
• Multifilament - The multifilament segment is a key part of the market, fueled by the rising demand for advanced wound closure in complex, high-tension procedures, especially in orthopedics, cardiology, and general surgery. Braided sutures, known for their superior knot strength and flexibility, hold a 42% market share.

North America Surgical Sutures Market, By Application, 2025 (%)

• General Surgery - The general surgery segment is the leading and most significant area in the market. This is due to a high number of procedures, an aging population with chronic illnesses, and the essential need for dependable wound closure in both elective and emergencies. Surgical sutures are widely used in abdominal and routine surgeries, holding a 31% market share.
• Ophthalmic Surgery - The ophthalmic surgery segment plays a vital role in the market. Its significance comes from a high volume of age-related procedures, the requirement for specialized high-precision materials, and fast technological progress in synthetic, non-absorbable, and antimicrobial sutures. Specialized sutures made for delicate eye surgeries account for an 11% share, driven by the growing demand for cataract and retinal surgeries.

Competitive Landscape

• Ethicon (Johnson & Johnson) is a market leader with a wide range of products, especially in antimicrobial sutures and barbed sutures such as Stratafix, supported by a robust distribution network.
• Medtronic is a major player that concentrates on absorbable and specialty sutures for minimally invasive and robotic-assisted surgeries, enhancing its role in complex procedures.
• B. Braun SE is recognized for its high-quality, biocompatible synthetic sutures, prioritizing safety, ease of use, and affordable biodegradable options.
• Teleflex Incorporated holds a strong market position with a varied portfolio that includes specialty and procedural sutures.
• DemeTECH Corporation is a well-known American manufacturer offering a broad range of absorbable and non-absorbable sutures.
• Smith and Nephew have a strong foothold in orthopedic and general surgery, focusing on cutting-edge suture materials.
• Conmed Corporation specializes in suture products tailored for sports medicine and general surgery.
• Corza Medical is an emerging company with a significant portfolio aimed at improving procedural efficiency.

Segments Covered in the Report

By Type

• Absorbable
• Non-absorbable

By Filament

• Monofilament
• Multifilament

By Application

• General Surgery
• Ophthalmic Surgery
• Cardiovascular Surgery
• Orthopedic Surgery
• Neurological Surgery
• Others